age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
78.44995
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
| null | 0
| 25,633
| 15,443.7422
| 14,184.5
| 10.5
|
white
| 21.597656
| 33
| 0.694946
| 0.530884
| 6
| 0
| 0
|
yes
| 0.3
| 0.05
|
no dnr
| 9
| 97
| 6.599609
| 60
| 20
| 36.09375
| 224
| null | null | 0.699951
| 141
| 7.299805
| 183
| 7
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 107
| 1
|
73.37994
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
| null | 0
| 4,327
| 2,242.1426
| 2,075.13867
| 16
|
white
| 16.5
| 29
| 0.873901
| 0.790894
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 4
| 80
| 13.5
| 180
| 20
| 36.09375
| 260
| null | null | 0.699951
| 138
| 7.419922
| 82
| 8
| 850
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 782
| 0
|
73.89697
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 17
|
$25-$50k
| 0
| 13,112
| 7,688.0469
| 6,305.33984
| 13
|
white
| 18.898438
| 29
| 0.846924
| 0.748901
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 9
| 39
| 31.398438
| 118
| 28
| 37.29688
| 70
| 1.5
| 0.599976
| 2.5
| 136
| 7.109375
| 230
| 51
| 50
| 0
| 1
|
<2 mo. follow-up
| 1
| 29
| 1
|
41.91898
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 15
|
$25-$50k
| 0
| 86,133
| 59,003.0312
| 41,610.25
| 40.333313
|
white
| 28
| 28
| 0.827881
| 0.768921
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 21
| 65
| 17.597656
| 116
| 16
| 37.89844
| null | 2.099609
| 2.099609
| 1.099854
| 132
| null | 109
| 29
| 450
| null | 0
|
no(M2 and SIP pres)
| 0
| 780
| 0
|
81.16595
|
male
| 0
| 28
|
Lung Cancer
|
Cancer
| 2
| 24
|
$25-$50k
| 9
| 32,597
| 18,775.0156
| 23,421.4219
| 9.25
|
white
| 18.796875
| 22
| 0.587891
| 0.267944
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.3
|
dnr after sadm
| 7
| 107
| 7.299805
| 72
| 24
| 36.89844
| 262.9375
| null | null | 2.199707
| 139
| 7.40918
| 129
| 54
| 1,450
| null | 4
|
<2 mo. follow-up
| 4
| 32
| 1
|
22.63399
|
male
| 0
| 154
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
>$50k
| 0
| 489,823
| 279,177.75
| 236,234.5
| 51.5
|
white
| 35.695313
| 50
| 0.783936
| 0.713989
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
no dnr
| 154
| 127
| 20.296875
| 130
| 40
| 38.19531
| 132
| 2.099609
| null | 0.599976
| 146
| 7.439453
| 111
| 9
| 1,016
| null | 0
|
Coma or Intub
| 0
| 779
| 0
|
84.49298
|
female
| 0
| 86
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| null | null | 0
| 183,705
| null | null | 37.25
|
white
| 19.699219
| 54
| 0.700928
| 0.610962
| 1
| 1
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 86
| 111
| 17.699219
| 105
| 16
| 35.59375
| 195.21875
| 3.799805
| 0.599976
| 4.699219
| 132
| 7.489258
| 119
| 23
| 0
| null | null |
adl>=4 (>=5 if sur)
| 3.76416
| 206
| 1
|
18.754
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
| null | 0
| 15,711
| 11,459.125
| 9,782.89844
| 16
|
other
| 28.796875
| 38
| 0.878906
| 0.835938
| 1
| 0
| 0
|
no
| 0.98
| 0.98
|
no dnr
| 8
| 124
| 16.097656
| 50
| 24
| 38.5
| 105
| null | null | 1.5
| 142
| 7.399414
| 172
| 35
| 1,664
| 0
| 1
|
no(M2 and SIP pres)
| 1
| 777
| 0
|
77.05695
|
male
| 0
| 11
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 16
| null | 0
| 23,606
| 13,628.6641
| 13,242.6562
| 13
|
white
| 24.097656
| 37
| 0.616943
| 0.511963
| 6
| 1
| 0
|
yes
| 0.6
| 0.5
|
no dnr
| 11
| 52
| 7
| 120
| 29
| 36.79688
| 95.90625
| null | null | 0.899902
| 131
| 7.489258
| 95
| 17
| 4,300
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 70
| 1
|
82.86395
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 41
| 26,475
| 15,379.2031
| 8,938.91406
| 24
|
white
| 28.5
| 52
| 0.457947
| 0.337952
| 1
| 1
| 0
|
no
| 0.2
| 0.2
|
dnr after sadm
| 2
| 63
| 16.398438
| 60
| 4
| 36.59375
| 65
| null | 0.299988
| 0.799927
| 145
| 7.329102
| 253
| 15
| 2,275
| null | null |
<2 mo. follow-up
| 3.026367
| 6
| 1
|
64.81598
|
female
| 0
| 79
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
$11-$25k
| 0
| 227,656
| 150,149
| 134,263.625
| 41
|
white
| 26.398438
| 24
| 0.714966
| 0.62793
| 8
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 79
| 67
| 7.299805
| 80
| 20
| 37
| 271.375
| 2.899902
| 6.5
| 1.5
| 140
| 7.469727
| 183
| 21
| 1,200
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 776
| 0
|
91.25
|
female
| 0
| 7
|
Lung Cancer
|
Cancer
| 3
| 12
| null | 0
| 6,621
| 3,815.6055
| 715.7998
| 3
|
white
| 24.199219
| 43
| 0.449951
| 0.13797
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.2
|
dnr after sadm
| 3
| 59
| 5
| 120
| 24
| 35.79688
| 261.875
| null | null | 3.799805
| 139
| 7.279297
| 88
| 86
| 490
| 2
| 3
|
<2 mo. follow-up
| 3
| 10
| 1
|
73.54999
|
male
| 0
| 16
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 37,467
| 26,889.4062
| 21,578.0469
| 17
|
white
| 28.597656
| 61
| 0.498962
| 0.381958
| 1
| 0
| 0
|
metastatic
| 0.85
| 0.6
|
dnr after sadm
| 14
| 77
| 8.699219
| 70
| 25
| 36.69531
| 305
| 2.299805
| 1.099854
| 1.099854
| 140
| 7.479492
| 106
| 14
| 4,745
| 1
| 1
|
<2 mo. follow-up
| 1
| 43
| 1
|
84.64899
|
female
| 1
| 3
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 100
| 10,739
| 5,883.5078
| 4,961.9375
| 34
|
white
| 36
| 64
| 0.001
| 0
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 3
| 60
| 14.699219
| 1
| 40
| 36.89844
| 100
| 2
| 1.899902
| 2.099609
| 136
| 7.449219
| 172
| 26
| 972
| null | null |
<2 mo. follow-up
| 3.404785
| 3
| 1
|
34.45898
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 3,212
| 1,865.0439
| 1,924.53906
| null |
black
| 9.898438
| 19
| 0.966919
| 0.942993
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 3
| 51
| 4.5
| 79
| 25
| 36.09375
| null | null | 0.5
| 1.199951
| 138
| null | 101
| 16
| 750
| null | null |
no(M2 and SIP pres)
| 1.723633
| 773
| 0
|
94.28894
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
| null | 0
| 4,854
| 35,284.0938
| 24,298.8594
| 24.333328
|
white
| 18.898438
| 25
| 0.778931
| 0.707886
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 18
| 120
| 7.699219
| 70
| 20
| 35.59375
| null | null | null | 1.099854
| 137
| null | 250
| 21
| 1,000
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 772
| 0
|
65.65594
|
female
| 0
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 20
|
>$50k
| 0
| 14,770
| 10,889.8672
| 8,702.69531
| 19
|
white
| 25.898438
| 24
| 0.748901
| 0.669922
| 3
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 5
| 105
| 12
| 60
| 24
| 36.59375
| null | 3.799805
| 1.799805
| 1.899902
| 139
| null | 124
| 44
| 1,175
| null | null |
no(M2 and SIP pres)
| 1.952148
| 771
| 0
|
77.14697
|
male
| 0
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 16
|
under $11k
| 0
| 6,100
| 3,419.4824
| 3,175.78906
| null |
white
| 23.097656
| 51
| 0.777954
| 0.705933
| 1
| 0
| 0
|
no
| 1
| 0.9
|
no dnr
| 3
| 79
| 12.599609
| 106
| 30
| 38.09375
| 106.65625
| 2.699707
| 0.199982
| 0.699951
| 133
| 7.389648
| 101
| 13
| 7,130
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 769
| 0
|
63.17899
|
male
| 0
| 3
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 22
|
>$50k
| 0
| 4,222
| 2,193.7207
| 2,169.21875
| null |
white
| 16.296875
| 19
| 0.873901
| 0.789917
| 1
| 0
| 0
|
yes
| 0.85
| 0.5
|
no dnr
| 3
| 73
| 8
| 80
| 16
| 36.09375
| null | 3.199707
| null | 1.299805
| 142
| null | 61
| 27
| 1,770
| null | null |
no(M2 and SIP pres)
| 2.115723
| 426
| 1
|
69.42395
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 10
| null | 0
| 7,165
| 4,281.4922
| 4,088.9082
| 23
|
white
| 13.099609
| 11
| 0.768921
| 0.521973
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 6
| 56
| 12
| 130
| 14
| 40.09375
| 58
| 2.299805
| 0.699951
| 0.799927
| 136
| 7.369141
| 119
| 8
| 2,320
| 2
| null |
no(M2 and SIP pres)
| 1.838867
| 256
| 1
|
83.23596
|
female
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 44
| 6,498
| 11,080.0312
| 6,928.82812
| 26
|
white
| 19
| 28
| 0.682983
| 0.589966
| 1
| 0
| 1
|
no
| 0.7
| 0.65
|
dnr before sadm
| 0
| 53
| 8.099609
| 60
| 8
| 38
| 278
| 2.599609
| null | 0.699951
| 149
| 7.459961
| 169
| 19
| 349
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 768
| 0
|
24.474
|
female
| 0
| 22
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
| null | 0
| 84,800
| 62,121.2188
| 47,555.4375
| 42
|
hispanic
| 27.597656
| 32
| 0.86792
| 0.821899
| 2
| 0
| 0
|
no
| 0.65
| 0.65
|
no dnr
| 22
| 67
| 12.798828
| 112
| 58
| 38.89844
| 169.375
| null | null | 0.599976
| 141
| 7.439453
| 121
| 2
| 1,375
| null | 1
|
SIP>=30
| 1
| 767
| 0
|
34.47198
|
female
| 0
| 24
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 17
|
$25-$50k
| 0
| 89,616
| 51,243.75
| 42,702.9062
| 36.333313
|
white
| 36
| 51
| 0.647949
| 0.547974
| 2
| 1
| 0
|
yes
| null | null |
no dnr
| 24
| 80
| 21.097656
| 70
| 20
| 36.09375
| 321
| 3.299805
| null | 6.5
| 134
| 7.289062
| 599
| 91
| 1,315
| null | 0
|
no(M2 and SIP pres)
| 0
| 767
| 0
|
37.02698
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 11
|
$11-$25k
| 0
| 7,813
| 4,125.1992
| 4,440.92969
| 14
|
white
| 20
| 13
| 0.91394
| 0.881958
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 65
| 12
| 131
| 52
| 38.59375
| 368
| 2.799805
| 0.599976
| 1.899902
| 150
| 7.419922
| 168
| 78
| 1,445
| null | null |
no(M2 and SIP pres)
| 1.804199
| 766
| 0
|
85.06494
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
$25-$50k
| 0
| 34,245
| 20,162.6406
| 19,093.2188
| 21.5
|
white
| 23.898438
| 38
| 0.633911
| 0.531982
| 3
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 12
| 96
| 9.199219
| 68
| 10
| 36.79688
| 93.75
| 2.399902
| 0.399963
| 0.599976
| 130
| 7.399414
| 82
| 17
| 2,030
| 0
| 0
|
adl>=4 (>=5 if sur)
| 0
| 94
| 1
|
89.74097
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 17,130
| 10,323.2422
| 9,630.22656
| 10
|
white
| 19.097656
| 28
| 0.792969
| 0.724976
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
dnr after sadm
| 1
| 60
| 14.798828
| 110
| 30
| 36.59375
| 195.625
| null | null | 0.699951
| 144
| 7.449219
| 83
| 22
| null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 765
| 0
|
54.09399
|
female
| 0
| 20
|
Lung Cancer
|
Cancer
| 4
| 14
|
$11-$25k
| 9
| 16,905
| 10,727.7969
| 10,655.5234
| 7.333332
|
white
| 17.199219
| 13
| 0.696899
| 0.408997
| 1
| 1
| 0
|
metastatic
| 0.2
| 0.05
|
dnr before sadm
| -1
| 110
| 15.5
| 146
| 11
| 36.19531
| 268
| 4.799805
| 0.399963
| 2.199707
| 142
| 7.329102
| 111
| 47
| 1,275
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 62
| 1
|
51.38898
|
male
| 0
| 17
|
Lung Cancer
|
Cancer
| 4
| 13
|
$11-$25k
| 0
| 41,738
| 21,054.7188
| 19,482.7812
| 13.666664
|
white
| 17.5
| 13
| 0.728882
| 0.45697
| 1
| 0
| 0
|
metastatic
| 0.7
| 0.5
|
no dnr
| 17
| 51
| 4.899414
| 60
| 6
| 35.19531
| 130.59375
| 2.899902
| 0.5
| 2.299805
| 141
| 7.099609
| 204
| 80
| 1,090
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 183
| 1
|
67.49597
|
female
| 0
| 10
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 13,784
| 8,026.0547
| 7,459.4375
| 10.5
|
white
| 23
| 35
| 0.56189
| 0.23999
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.15
|
dnr before sadm
| -1
| 113
| 4.099609
| 60
| 25
| 36.69531
| null | 4.5
| null | 1.299805
| 143
| null | 60
| 13
| null | 2
| 0
|
no(M2 and SIP pres)
| 0
| 123
| 1
|
34.793
|
female
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 10
|
under $11k
| 0
| 10,315
| 6,516.2422
| 5,583.76953
| 11
|
black
| 32.695313
| 45
| 0.785889
| 0.715942
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 7
| 122
| 12.298828
| 102
| 8
| 37.79688
| 250
| 3.299805
| null | 0.799927
| 134
| 7.449219
| 155
| 23
| 1,035
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 761
| 0
|
78.086
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 11
|
$11-$25k
| 0
| 43,260
| 31,237.7344
| 22,989.7344
| 49
|
white
| 22.796875
| 26
| 0.778931
| 0.706909
| 1
| 1
| 0
|
no
| 0.25
| 0
|
dnr after sadm
| 9
| 73
| 19
| 68
| 26
| 36.09375
| 134.6875
| null | null | 0.799927
| 135
| 7.40918
| 106
| 14
| 1,970
| null | 6
|
<2 mo. follow-up
| 6
| 11
| 1
|
54.79797
|
male
| 1
| 30
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 43,582
| 24,543.3906
| 19,447.6562
| 14.5
|
white
| 18.796875
| 17
| 0.696899
| 0.408997
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.1
|
no dnr
| 30
| 159
| 9.099609
| 128
| 42
| 36.59375
| null | 4.599609
| 0.799927
| 2
| 141
| null | 91
| 33
| 3,748
| null | null |
<2 mo. follow-up
| 2.833496
| 30
| 1
|
75.12897
|
male
| 0
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 44
| 16,763
| 9,901.5234
| 9,683.14844
| 17
|
white
| 20.699219
| 34
| 0.497986
| 0.380981
| 1
| 0
| 0
|
metastatic
| 0.5
| 0.25
|
dnr after sadm
| 1
| 93
| 8
| 110
| 20
| 35.59375
| 218.3125
| 4.299805
| null | 1.299805
| 142
| 7.459961
| 76
| 23
| 3,800
| 1
| 4
|
<2 mo. follow-up
| 4
| 51
| 1
|
71.51794
|
female
| 0
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
under $11k
| 0
| 41,046
| 27,401.8438
| 22,972.2969
| 12
|
white
| 19.898438
| 43
| 0.819946
| 0.759888
| 3
| 0
| 1
|
no
| 0.8
| 0.6
|
no dnr
| 20
| 73
| 6.099609
| 80
| 20
| 37.79688
| null | null | null | 0.799927
| 138
| null | 71
| 6
| 3,000
| null | 1
|
no(M2 and SIP pres)
| 1
| 759
| 0
|
77.88098
|
female
| 0
| 15
|
Lung Cancer
|
Cancer
| 1
| 11
| null | 0
| 19,490
| 10,861.7734
| 14,773.5078
| 9.666664
|
white
| 22.199219
| 32
| 0.55188
| 0.228973
| 1
| 0
| 0
|
metastatic
| 0.25
| 0.5
|
dnr after sadm
| 3
| 63
| 14.599609
| 98
| 30
| 38.19531
| 242.5
| 3.199707
| null | 1.399902
| 144
| 7.419922
| 174
| 41
| 2,280
| null | 1
|
<2 mo. follow-up
| 1
| 38
| 1
|
76.96594
|
male
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 3
|
under $11k
| 9
| 22,398
| 13,414.8828
| 11,736.5156
| 24
|
white
| 18.898438
| 38
| 0.816895
| 0.755981
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 11
| 131
| 25.199219
| 103
| 14
| 38.09375
| 76.25
| 2.699707
| 0.5
| 0.699951
| 144
| 7.469727
| 144
| 11
| 4,815
| null | null |
<2 mo. follow-up
| 2.592773
| 23
| 1
|
56.06299
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 4
| 1
|
$11-$25k
| 0
| 18,205
| 9,173.8828
| 2,848.13867
| 11
|
white
| 15.599609
| 17
| 0.75293
| 0.495972
| 1
| 1
| 0
|
metastatic
| 0.75
| 0.4
|
no dnr
| 4
| 121
| 25.199219
| 71
| 12
| 35
| 111.42188
| 2.699707
| 2.699707
| 4.299805
| 146
| 7.489258
| 98
| 76
| 2,922
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 343
| 1
|
43.87698
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
>$50k
| 0
| 19,006
| 12,625.0234
| 10,735.7734
| 14.5
|
white
| 28.296875
| 36
| 0.817993
| 0.756958
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 108
| 11.599609
| 84
| 20
| 36.39844
| 400
| 4.399414
| null | 0.399963
| 138
| 7.539062
| 122
| 2
| 3,900
| 1
| 1
| null | 1
| 753
| 0
|
73.80396
|
female
| 0
| 24
|
Colon Cancer
|
Cancer
| 1
| null | null | 0
| 34,604
| 22,847.0469
| 10,442.0938
| 20.666656
|
white
| 23.398438
| 31
| 0.687988
| 0.395996
| 1
| 0
| 0
|
metastatic
| 0.1
| 0.1
|
dnr after sadm
| 20
| 49
| 7
| 63
| 28
| 38.39844
| null | null | null | 1.599854
| 142
| null | 84
| 21
| 1,935
| null | null | null | 2.598633
| 60
| 1
|
76.20294
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 5
| 9
|
$25-$50k
| 0
| 14,896
| 7,059.4922
| 8,299.90625
| 4.5
|
white
| 16.699219
| 18
| 0.687988
| 0.395996
| 1
| 1
| 0
|
metastatic
| 0.2
| 0
|
no dnr
| 7
| 70
| 6
| 62
| 14
| 36.69531
| 203.3125
| 4
| 1
| 1.399902
| 142
| 7.189453
| 106
| 42
| 1,710
| 5
| null |
<2 mo. follow-up
| 3.854981
| 24
| 1
|
71.63599
|
male
| 0
| 7
|
Lung Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 15,393
| 8,254.8359
| 5,255.54688
| 6.5
|
white
| 16.097656
| 14
| 0.710938
| 0.429993
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.2
|
no dnr
| 7
| 113
| 7.199219
| 100
| 20
| 36.09375
| null | null | 0.399963
| 0.899902
| 136
| null | 286
| 14
| null | 0
| 6
| null | 6
| 366
| 1
|
73.18298
|
female
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 8
| null | 0
| 26,832
| null | null | 21.5
|
white
| 20
| 33
| 0.823975
| 0.713989
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 12
| 69
| 11.898438
| 108
| 20
| 38.59375
| null | null | 0.699951
| 0.899902
| 137
| null | 81
| 7
| 2,850
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 750
| 0
|
70.90997
|
female
| 0
| 24
|
Coma
|
Coma
| 0
| 6
|
>$50k
| 100
| 48,963
| 27,923
| 26,209.25
| 20.666656
|
white
| 20.898438
| 24
| 0.234985
| 0.169983
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 5
| 77
| 15.398438
| 120
| 25
| 36.09375
| null | null | null | 1
| 138
| null | 123
| 20
| 700
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 749
| 0
|
73.125
|
female
| 1
| 82
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 282,678
| 170,951.875
| 158,507.125
| 35.25
|
white
| 27.097656
| 72
| 0.723999
| 0.638916
| 1
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 82
| 53
| 10.599609
| 59
| 36
| 36.69531
| 100
| 2.799805
| 0.599976
| 0.799927
| 133
| 7.5
| 84
| 14
| 500
| 2
| 3
|
SIP>=30
| 3
| 82
| 1
|
68.78296
|
female
| 0
| 16
|
Coma
|
Coma
| 3
| 6
| null | 44
| 31,924
| 20,235.625
| 16,678.875
| 18.333328
|
black
| 21.097656
| 42
| 0.537964
| 0.467957
| 1
| 1
| 0
|
no
| 0.4
| 0.3
|
no dnr
| 16
| 61
| 15.798828
| 135
| 8
| 37.69531
| 175
| 2.5
| 0.399963
| 1
| 142
| 7.359375
| 301
| 19
| 5,240
| null | 1
|
no(M2 and SIP pres)
| 1
| 604
| 1
|
71.625
|
male
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
under $11k
| 0
| 11,909
| 6,340.0938
| 6,590.71875
| 11
|
white
| 18.398438
| 22
| 0.824951
| 0.714966
| 1
| 0
| 0
|
yes
| 1
| 0.75
|
no dnr
| 9
| 97
| 6.399414
| 120
| 20
| 39.39844
| 276.1875
| null | null | 0.899902
| 139
| 7.479492
| 124
| 13
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 746
| 0
|
76.96399
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 114,257
| 63,974.1562
| 57,091.875
| 47.333313
|
white
| 32.898438
| 50
| 0.572998
| 0.461975
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 23
| 78
| 29.296875
| 68
| 10
| 35.69531
| 528.5
| 2.899902
| 1.299805
| 1.099854
| 139
| 7.339844
| 289
| 33
| 2,260
| null | 0
|
<2 mo. follow-up
| 0
| 23
| 1
|
45.40698
|
female
| 0
| 62
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 241,277
| 146,111.75
| 127,354.625
| 46.5
|
white
| 34.898438
| 53
| 0.459961
| 0.340942
| 12
| 0
| 0
|
metastatic
| 0.01
| 0
|
dnr after sadm
| 21
| 57
| 7.5
| 100
| 28
| 36.89844
| 369
| 3.099609
| null | 0.699951
| 139
| 7.5
| 97
| 5
| 370
| null | 0
|
SIP>=30
| 0
| 182
| 1
|
89.64496
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 18
|
$25-$50k
| 0
| 62,130
| 34,845
| 29,211.5469
| 47.5
|
white
| 23.5
| 45
| 0.666992
| 0.569946
| 5
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 10
| 77
| 9.099609
| 128
| 36
| 36.69531
| null | null | 0.399963
| 0.699951
| 143
| null | 104
| 13
| 1,050
| null | 0
|
<2 mo. follow-up
| 0
| 12
| 1
|
86.26697
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 9,107
| 5,198.6875
| 5,056.62891
| 13.5
|
white
| 21.898438
| 44
| 0.700928
| 0.537964
| 1
| 0
| 0
|
no
| 0.1
| 0.01
|
dnr before sadm
| -1
| 79
| 15.398438
| 63
| 32
| 38.69531
| 316
| 3.399902
| 1.599854
| 0.799927
| 136
| 7.509766
| 203
| 46
| 1,910
| 2
| 3
|
<2 mo. follow-up
| 3
| 25
| 1
|
80.30695
|
female
| 0
| 46
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 0
| 53,620
| 32,645.9688
| 17,730.3281
| 18.5
|
white
| 25.097656
| 38
| 0.72998
| 0.646973
| 1
| 0
| 0
|
no
| 0.2
| 0
|
dnr after sadm
| 2
| 71
| 9.798828
| 88
| 26
| 37.69531
| null | null | 0.5
| 1.199951
| 134
| null | 169
| 13
| 7,650
| 0
| 3
|
no(M2 and SIP pres)
| 3
| 299
| 1
|
59.06598
|
female
| 0
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 13
|
>$50k
| 0
| 6,445
| 4,533.3242
| 3,647.95898
| 4
|
white
| 17
| 24
| 0.897949
| 0.860962
| 1
| 0
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 4
| 57
| 3.899902
| 115
| 25
| 38
| 338.0625
| 3
| 1.099854
| 0.5
| 134
| 7.549805
| 126
| 3
| 3,550
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 741
| 0
|
78.05597
|
female
| 0
| 23
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
under $11k
| 0
| 45,659
| 28,706.2969
| 25,184.7344
| 24.666656
|
white
| 29.796875
| 61
| 0.602905
| 0.41394
| 1
| 0
| 0
|
no
| 0.5
| 0.7
|
no dnr
| 23
| 63
| 18.898438
| 76
| 26
| 36.19531
| null | 2
| null | 0.799927
| 143
| null | 159
| 15
| 750
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 122
| 1
|
76.04095
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 20
|
$11-$25k
| 0
| 10,911
| 8,963.7969
| 7,079.84766
| 21
|
white
| 18.296875
| 21
| 0.829956
| 0.7229
| 1
| 0
| 0
|
no
| 0.1
| 0.05
|
dnr after sadm
| 2
| 77
| 6.199219
| 80
| 20
| 36.09375
| null | 3.299805
| 0.599976
| 1
| 138
| null | 73
| 23
| null | 0
| null |
SIP>=30
| 0.494751
| 726
| 0
|
78.06696
|
female
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 33,427
| 18,798.0781
| 17,920.1562
| 16
|
white
| 15.099609
| 8
| 0.875
| 0.792969
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 16
| 73
| 5.099609
| 100
| 24
| 36.79688
| null | null | null | 1.099854
| 143
| null | 92
| 19
| 3,500
| null | null |
<2 mo. follow-up
| 2.627441
| 17
| 1
|
67.17297
|
male
| 1
| 56
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
| null | 0
| 214,919
| 133,772.875
| 119,766.562
| 44.25
|
white
| 31.5
| 39
| 0.513916
| 0.397949
| 1
| 1
| 0
|
metastatic
| 0.5
| 0
|
dnr after sadm
| 27
| 58
| 6.299805
| 73
| 40
| 38.29688
| 175
| null | null | 1.199951
| 134
| 7.429688
| 171
| 19
| 2,094
| null | 0
|
<2 mo. follow-up
| 0
| 56
| 1
|
61.88599
|
female
| 1
| 3
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
|
under $11k
| 0
| 22,855
| 12,007.4844
| 9,467.47656
| 51
|
white
| 33.195313
| 53
| 0.652954
| 0.553955
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 3
| 68
| 12.599609
| 66
| 10
| 38.5
| 158
| 2.799805
| 0.599976
| 0.5
| 138
| 7.449219
| 118
| 21
| 2,184
| null | null |
<2 mo. follow-up
| 2.131348
| 3
| 1
|
76.07397
|
male
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 17
| null | 0
| 12,470
| 7,309.4531
| 6,533.09766
| 5
|
white
| 18.699219
| 23
| 0.782959
| 0.651978
| 1
| 0
| 0
|
yes
| 0.5
| 0.2
|
dnr after sadm
| 1
| 58
| 3.699707
| 67
| 28
| 38.5
| 211.65625
| 1.799805
| null | 5
| 139
| 7.299805
| 94
| 109
| 215
| 6
| 7
|
<2 mo. follow-up
| 7
| 32
| 1
|
69.81195
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
>$50k
| 0
| 8,025
| 4,081.2266
| 5,767.39844
| 8
|
white
| 15.599609
| 10
| 0.886963
| 0.810913
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 3
| 62
| 8.398438
| 64
| 31
| 37.89844
| 277.5
| null | 1
| 3.199707
| 140
| 7.339844
| 247
| 58
| 1,194
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 724
| 0
|
90.073
|
male
| 1
| 7
|
Coma
|
Coma
| 1
| 8
| null | 100
| 9,079
| 5,025.3203
| 4,395.57812
| 11
|
white
| 27.199219
| 53
| 0.014999
| 0.006
| 1
| 0
| 0
|
no
| 0.33
| 0.33
|
dnr after sadm
| 7
| 73
| 11.199219
| 70
| 15
| 37.79688
| 290.4375
| null | null | 1.699951
| 132
| 7.459961
| 66
| 15
| 2,000
| null | 7
|
<2 mo. follow-up
| 7
| 7
| 1
|
74.68298
|
male
| 1
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 13
|
under $11k
| 0
| 31,918
| 24,692.5
| 19,064.6719
| 36
|
white
| 28.597656
| 22
| 0.620972
| 0.516968
| 1
| 0
| 0
|
yes
| 0.75
| 0.65
|
dnr after sadm
| 5
| 63
| 22.699219
| 117
| 10
| 39.39844
| 91
| 3
| 1.799805
| 1.699951
| 147
| 7.419922
| 181
| 52
| 1,535
| null | 0
|
<2 mo. follow-up
| 0
| 10
| 1
|
66.23096
|
male
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 9
|
under $11k
| 0
| 16,752
| 11,609.2812
| 9,339.26562
| 17
|
white
| 16.5
| 20
| 0.886963
| 0.8479
| 1
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 6
| 67
| 11.199219
| 140
| 16
| 36.5
| 93.32812
| 2.799805
| 5.099609
| 0.699951
| 141
| 7.439453
| 55
| 11
| 1,516
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 722
| 0
|
72.31995
|
female
| 1
| 23
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 10
|
$11-$25k
| 0
| 67,687
| 38,645.4062
| 34,834.6875
| 31.666656
|
other
| 33
| 62
| 0.396973
| 0.276978
| 4
| 0
| 0
|
yes
| 0.5
| 0.25
|
dnr after sadm
| 5
| 65
| 11.398438
| 70
| 8
| 36.19531
| 178
| 2.399902
| 0.599976
| 2
| 135
| 7.479492
| 69
| 43
| 1,745
| null | 6
|
<2 mo. follow-up
| 6
| 23
| 1
|
49.59299
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 14
|
$11-$25k
| 0
| 23,496
| 18,205.4531
| 16,071.7656
| 19.5
|
black
| 28.5
| 65
| 0.794922
| 0.727905
| 1
| 0
| 0
|
no
| 0.7
| 0.7
|
no dnr
| 10
| 110
| 9.798828
| 100
| 25
| 36.09375
| 326.625
| 4
| null | 7
| 144
| 7.199219
| 128
| 127
| 650
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 717
| 0
|
72.49298
|
female
| 0
| 20
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
>$50k
| 9
| 40,801
| 26,217.1719
| 21,126.7344
| 33
|
white
| 36.195313
| 42
| 0.315979
| 0.202972
| 1
| 0
| 0
|
yes
| 0.5
| 0.1
|
dnr before sadm
| 0
| 63
| 13.398438
| 72
| 22
| 36.69531
| 446.625
| 2.399902
| 1.399902
| 3
| 130
| 7.389648
| 107
| 138
| 2,230
| 0
| 6
|
<2 mo. follow-up
| 6
| 24
| 1
|
75.35095
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| null | null | 44
| 24,854
| 17,060.5
| 14,763.1328
| 20.5
|
black
| 26.5
| 57
| 0.54895
| 0.434998
| 1
| 1
| 1
|
no
| 0.6
| 0.4
|
dnr after sadm
| 1
| 143
| 8.898438
| 80
| 20
| 36.09375
| 304.75
| null | 1.199951
| 1.599854
| 142
| 7.459961
| 76
| 19
| 3,500
| null | null |
<2 mo. follow-up
| 6.279297
| 12
| 1
|
65.69495
|
female
| 0
| 6
|
Lung Cancer
|
Cancer
| 1
| null |
$11-$25k
| 0
| 11,757
| 5,935.3398
| 4,202.27734
| 14
|
white
| 17.097656
| 13
| 0.704956
| 0.419983
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
no dnr
| 6
| 59
| 29.199219
| 60
| 22
| 35.89844
| 233.3125
| 3.199707
| 0.299988
| 2.099609
| 128
| 7.379883
| 154
| 65
| 3,000
| 2
| 0
|
<2 mo. follow-up
| 0
| 45
| 1
|
53.89499
|
female
| 1
| 8
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$25-$50k
| 0
| 36,722
| 26,371.9219
| 21,518.4844
| 34.5
|
white
| 35.09375
| 46
| 0.345947
| 0.22998
| 1
| 0
| 0
|
metastatic
| 0.45
| 0.1
|
dnr after sadm
| 5
| 77
| 8.699219
| 62
| 24
| 36.09375
| 217.375
| 3.399902
| 0.5
| 1.399902
| 131
| 7.359375
| 176
| 39
| 3,175
| 2
| 6
|
<2 mo. follow-up
| 6
| 8
| 1
|
71.59998
|
female
| 0
| 11
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 18
|
$25-$50k
| 0
| 15,622
| 8,136.7266
| 8,532.90625
| 14.5
|
white
| 19.097656
| 28
| 0.843994
| 0.743896
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 11
| 73
| 5.5
| 60
| 20
| 36.69531
| null | null | 0.599976
| 1.199951
| 137
| null | 102
| 13
| 2,600
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 358
| 1
|
49.495
|
female
| 0
| 13
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 45,617
| 25,077.0781
| 26,652.125
| 29.5
|
black
| 18.898438
| 30
| 0.907959
| 0.843994
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 13
| 47
| 13.798828
| 176
| 8
| 38.39844
| 190
| 2.599609
| 0.899902
| 0.799927
| 146
| 7.379883
| 251
| 16
| 4,505
| 1
| 1
|
no(M2 and SIP pres)
| 1
| 710
| 0
|
90.27795
|
female
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 10
| null | 0
| 29,200
| 18,691.5781
| 18,738.6406
| 17.333328
|
white
| 19.199219
| 37
| 0.789917
| 0.720947
| 1
| 0
| 0
|
no
| 0.6
| 0.5
|
dnr after sadm
| 1
| 68
| 7
| 80
| 20
| 35.89844
| 180
| 2
| 6.099609
| 0.899902
| 132
| 7.299805
| 117
| 24
| 1,425
| 3
| 6
|
<2 mo. follow-up
| 6
| 42
| 1
|
77.14697
|
male
| 0
| 15
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 0
| 74,562
| 39,255.3125
| 40,547.7812
| 33.333313
|
white
| 24.296875
| 25
| 0.712891
| 0.625977
| 5
| 0
| 0
|
no
| 0.6
| 0.216
|
no dnr
| 15
| 48
| 17
| 142
| 26
| 39
| 196.65625
| 3
| 0.899902
| 1.5
| 136
| 7.429688
| 370
| 35
| 2,221
| null | null | null | 2.800293
| 606
| 1
|
71.64996
|
male
| 0
| 20
|
COPD
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$25-$50k
| 0
| 26,614
| 14,004.4609
| 13,184.3438
| 16
|
white
| 17.398438
| 27
| 0.827881
| 0.719971
| 1
| 1
| 0
|
yes
| 1
| 1
|
dnr after sadm
| 15
| 97
| 11.898438
| 80
| 20
| 35
| 233.3125
| null | null | 1.099854
| 139
| 7.399414
| 139
| 39
| 550
| 0
| 3
|
SIP>=30
| 3
| 196
| 1
|
70.17395
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 8
|
under $11k
| 0
| 30,650
| 20,517.8594
| 16,421.3281
| 27
|
white
| 23.796875
| 34
| 0.792969
| 0.724976
| 1
| 0
| 1
|
no
| 0.7
| 0.5
|
no dnr
| 13
| 93
| null | 97
| 24
| 36.79688
| 304.3125
| null | null | 0.899902
| 141
| 7.399414
| 112
| 29
| null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 709
| 0
|
44.32898
|
female
| 0
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 18
|
$25-$50k
| 0
| 22,641
| 14,706.6016
| 12,632.0469
| 29
|
white
| 24.398438
| 19
| 0.654907
| 0.556885
| 1
| 0
| 0
|
metastatic
| 0.6
| 0.3
|
no dnr
| 9
| 53
| 20.5
| 80
| 30
| 37.79688
| null | null | null | 2.5
| 151
| null | 135
| 64
| 550
| 0
| null |
no(M2 and SIP pres)
| 0.494751
| 116
| 1
|
89.99896
|
female
| 1
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
>$50k
| 0
| 165,741
| null | null | 36.5
|
white
| 22.898438
| 48
| 0.728882
| 0.644897
| 1
| 0
| 0
|
no
| 0.6
| 0.6
|
dnr after sadm
| 1
| 42
| 14.599609
| 76
| 8
| 36.59375
| 230
| null | 0.599976
| 1.5
| 138
| 7.429688
| 154
| 14
| 3,885
| null | 5
|
<2 mo. follow-up
| 5
| 39
| 1
|
62.42798
|
male
| 1
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 3
|
under $11k
| 44
| 34,412
| 22,751.5938
| 18,237.7656
| 44
|
black
| 39.09375
| 87
| 0.271973
| 0.163971
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 70
| 11.199219
| 70
| 26
| 37
| 486.625
| 3.699707
| 0.399963
| 1
| 141
| 7.339844
| 95
| 11
| 1,800
| null | 6
|
<2 mo. follow-up
| 6
| 7
| 1
|
64.71198
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 25
|
>$50k
| 0
| 36,616
| 21,484
| 20,967.9688
| 22.666656
|
white
| 25.296875
| 35
| 0.78894
| 0.719971
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
no dnr
| 14
| 67
| 1
| 100
| 12
| 35.29688
| 351
| 1.899902
| 4
| 1.799805
| 144
| 7.379883
| 107
| 29
| 845
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 84
| 1
|
78.75995
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 61,702
| 41,052.375
| 35,482.4688
| 12.666664
|
white
| 16.898438
| 37
| 0.805908
| 0.741943
| 14
| 1
| 0
|
no
| 0.7
| 0.6
|
no dnr
| 18
| 111
| 12.699219
| 128
| 50
| 38.29688
| 261.875
| 3
| null | 7.799805
| 140
| 7.369141
| 126
| 82
| 1,600
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 706
| 0
|
86.70197
|
male
| 0
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 56,348
| 32,967.5312
| 34,517.5
| 12.666664
|
white
| 15.398438
| 26
| 0.757935
| 0.680908
| 11
| 0
| 1
|
yes
| 0.9
| 0.8
|
no dnr
| 14
| 63
| 0.099991
| 109
| 28
| 36
| 144
| 2.199707
| 0.699951
| 0.699951
| 146
| 7.439453
| 118
| 16
| 3,950
| null | 2
|
adl>=4 (>=5 if sur)
| 2
| 705
| 0
|
67.33496
|
female
| 0
| 14
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 15
|
$25-$50k
| 0
| 37,386
| 27,409.5781
| 21,789.2812
| 19.333328
|
white
| 34.195313
| 63
| 0.344971
| 0.228973
| 1
| 0
| 0
|
metastatic
| 0.3
| 0.1
|
dnr after sadm
| 7
| 50
| 7.799805
| 60
| 25
| 39.29688
| 472.5
| 2.699707
| null | 8.5
| 144
| 7.349609
| 76
| 63
| 40
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 94
| 1
|
85.97095
|
female
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
under $11k
| 0
| 40,860
| 23,068.5469
| 21,470.1406
| 46
|
white
| 26
| 58
| 0.623901
| 0.519897
| 6
| 1
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 5
| 105
| null | 70
| 20
| 36.19531
| 264
| null | null | null | 140
| 7.369141
| null | null | 3,300
| null | 2
|
<2 mo. follow-up
| 2
| 5
| 1
|
79.01398
|
male
| 1
| 58
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
$25-$50k
| 0
| 234,205
| 136,209.5
| 134,112.5
| 38.75
|
white
| 31.699219
| 55
| 0.519897
| 0.403992
| 6
| 1
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 44
| 93
| 3.799805
| 100
| 20
| 36.59375
| null | null | null | 1.399902
| 140
| null | 118
| 35
| null | null | 2
|
<2 mo. follow-up
| 2
| 58
| 1
|
50.155
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 4
| null | 0
| 16,569
| 11,694.7969
| 8,973.78906
| 12.5
|
black
| 25.296875
| 69
| 0.835938
| 0.779907
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 8
| 53
| 6.799805
| 126
| 38
| 37.59375
| 93.32812
| 3.699707
| 0.899902
| 1.399902
| 147
| 7.429688
| 84
| 28
| 2,480
| 0
| 3
|
adl>=4 (>=5 if sur)
| 3
| 702
| 0
|
77.06
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| null | null | 0
| 24,721
| 16,660.7188
| 14,882.7031
| 19
|
white
| 26.898438
| 47
| 0.678955
| 0.508911
| 1
| 0
| 0
|
no
| 0.8
| 0.6
|
no dnr
| 10
| 100
| 5.5
| 80
| 20
| 37.79688
| null | null | null | 3.5
| 138
| null | 179
| 90
| null | null | null | null | 3.611816
| 699
| 0
|
81.25897
|
male
| 1
| 5
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 17,124
| 11,060.8125
| 9,887.57812
| 20
|
white
| 39
| 69
| 0.283997
| 0.174988
| 1
| 0
| 0
|
yes
| 0.1
| 0.05
|
dnr before sadm
| 0
| 125
| 5.699219
| 62
| 30
| 36.5
| 205
| null | null | 1.399902
| 142
| 7.489258
| 98
| 21
| 1,350
| null | null |
<2 mo. follow-up
| 2.95459
| 5
| 1
|
75.58099
|
female
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4
| 12
|
under $11k
| 0
| 16,291
| 10,785.2656
| 8,693.63281
| 19
|
black
| 21.097656
| 37
| 0.767944
| 0.692993
| 1
| 1
| 0
|
yes
| 0.9
| 0.8
|
no dnr
| 12
| 65
| 5.399414
| 64
| 16
| 38.09375
| 285.6875
| null | null | 2
| 140
| 7.379883
| 103
| 26
| 690
| null | 7
|
adl>=4 (>=5 if sur)
| 7
| 186
| 1
|
48.97998
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 0
| 65,038
| 36,985.9375
| 36,788.5625
| 16.5
|
white
| 26.296875
| 27
| 0.768921
| 0.694946
| 16
| 0
| 0
|
no
| 0.8
| 0.8
|
no dnr
| 13
| 119
| 14.898438
| 62
| 24
| 38.79688
| 167.34375
| null | null | 2.299805
| 140
| 7.369141
| 125
| 31
| 1,965
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 695
| 0
|
53.75497
|
male
| 0
| 19
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 16
|
$25-$50k
| 9
| 29,567
| 15,931.1328
| 12,398.0547
| 11.333328
|
white
| 25.097656
| 29
| 0.714966
| 0.556885
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 19
| 110
| 6.099609
| 80
| 20
| 36.09375
| 200
| null | null | 1.399902
| 141
| 7.429688
| 104
| 25
| null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 695
| 0
|
85.46497
|
male
| 0
| 27
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 76,784
| 52,937.0625
| 44,614.4375
| 33.25
|
white
| 26.097656
| 51
| 0.619995
| 0.514893
| 1
| 0
| 0
|
yes
| 0.9
| 0.88
|
no dnr
| 27
| 50
| 6.799805
| 98
| 26
| 39.29688
| 235
| 2.899902
| 1.199951
| 1.099854
| 141
| 7.419922
| 283
| 38
| 2,155
| null | 1
|
adl>=4 (>=5 if sur)
| 1
| 472
| 1
|
88.20294
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$11-$25k
| 0
| 20,010
| 13,632.3438
| 11,574.7188
| 17.5
|
white
| 27.597656
| 47
| 0.637939
| 0.535889
| 1
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 2
| 35
| 11.898438
| 182
| 40
| 38.89844
| 154.28125
| null | null | 4.799805
| 135
| 7.289062
| 319
| 82
| 625
| null | 6
| null | 6
| 279
| 1
|
84.09296
|
male
| 0
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 21
|
$25-$50k
| 0
| 18,630
| 10,353.1406
| 8,559.98438
| 14.5
|
white
| 20.5
| 21
| 0.74292
| 0.662964
| 1
| 0
| 0
|
yes
| 0.6
| 0.4
|
dnr after sadm
| 1
| 66
| 4.5
| 62
| 16
| 36.59375
| 356
| 3.199707
| 5
| 0.599976
| 141
| 7.369141
| 130
| 8
| 4,530
| 5
| 6
|
SIP>=30
| 6
| 693
| 0
|
83.29895
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 15
| null | 0
| 5,048
| 2,602.3965
| 2,444.67969
| 10
|
white
| 23.898438
| 37
| 0.736938
| 0.586914
| 1
| 1
| 0
|
no
| 0.99
| 0.78
|
no dnr
| 4
| 68
| 27.097656
| 83
| 24
| 38
| 348
| null | null | 0.899902
| 141
| 7.40918
| 132
| 24
| 3,100
| 0
| null |
SIP>=30
| 0.494751
| 594
| 1
|
73.04596
|
female
| 0
| 67
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 13
|
under $11k
| 0
| 211,782
| 126,372.188
| 103,448.875
| 44.75
|
white
| 24.796875
| 50
| 0.765991
| 0.690918
| 1
| 0
| 0
|
no
| 0.25
| 0.25
|
no dnr
| 67
| 106
| 14.599609
| 62
| 10
| 37.89844
| 168.3125
| 2
| 0.299988
| 2.299805
| 138
| 7.209961
| 198
| 42
| 1,350
| null | 7
| null | 7
| 692
| 0
|
64.77795
|
female
| 0
| 36
|
CHF
|
COPD/CHF/Cirrhosis
| 9
| 11
|
under $11k
| 0
| 51,994
| 30,648.0625
| 28,667.5625
| 13.25
|
white
| 26.097656
| 34
| 0.783936
| 0.653931
| 1
| 1
| 0
|
no
| 0.8
| 0.7
|
dnr after sadm
| 27
| 47
| 16.796875
| 144
| 28
| 39.19531
| 168.3125
| 1.5
| 0.599976
| 2
| 132
| 7.289062
| 102
| 61
| 4,030
| 2
| 3
|
adl>=4 (>=5 if sur)
| 3
| 691
| 0
|
85.75995
|
female
| 0
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null |
under $11k
| 9
| 17,840
| 11,800.1875
| 10,354.2656
| 21
|
white
| 27.199219
| 45
| 0.598999
| 0.491943
| 2
| 0
| 0
|
no
| 0.3
| 0.1
|
dnr after sadm
| 2
| 72
| 13.798828
| 114
| 28
| 35.89844
| 258.3125
| 3.099609
| null | 1.5
| 145
| 7.469727
| 221
| 29
| 2,275
| null | 2
|
<2 mo. follow-up
| 2
| 19
| 1
|
78.05597
|
male
| 1
| 9
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 0
| 53,410
| 30,021.2031
| 25,955.8281
| 51
|
white
| 43.695313
| 99
| 0.070999
| 0.025997
| 2
| 1
| 0
|
metastatic
| 0.5
| 0.125
|
dnr after sadm
| 2
| 81
| 18.5
| 82
| 28
| 38.19531
| 218.34375
| 3
| 0.599976
| 1
| 133
| 7.459961
| 201
| 41
| 2,855
| null | null |
<2 mo. follow-up
| 3.237793
| 9
| 1
|
75.63599
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 26,626
| 18,746.7031
| 16,173.3125
| 20
|
white
| 16.296875
| 23
| 0.855957
| 0.762939
| 1
| 0
| 0
|
no
| 0.9
| 0.85
|
no dnr
| 10
| 111
| 7.299805
| 80
| 25
| 38.79688
| 316
| null | 1.5
| 1.299805
| 145
| 7.429688
| 121
| 42
| 3,815
| null | 0
|
no(M2 and SIP pres)
| 0
| 185
| 1
|
71.78094
|
male
| 0
| 25
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$25-$50k
| 0
| 46,370
| 28,051.75
| 27,075.7188
| 15.5
|
white
| 23.796875
| 58
| 0.695923
| 0.530884
| 3
| 0
| 0
|
yes
| 0.3
| 0.1
|
no dnr
| 25
| 101
| 0.199982
| 118
| 22
| 34.79688
| null | 2.199707
| 2.699707
| 0.799927
| 141
| null | 87
| 31
| 1,550
| null | 0
| null | 0
| 129
| 1
|
21.20699
|
female
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
| null | 0
| 31,912
| 24,281.7812
| 19,701.5938
| 21
|
white
| 25.5
| 43
| 0.888916
| 0.848999
| 3
| 0
| 0
|
no
| 1
| 1
|
no dnr
| 10
| 124
| 10
| 160
| 37
| 39.09375
| 356
| 2.699707
| 4.099609
| 1
| 149
| 7.459961
| 89
| 28
| 1,596
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 685
| 0
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.